Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit)

v3.22.4
Consolidated Statement of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
AOCI Attributable to Parent [Member]
Beginning Balance at Dec. 31, 2020 $ 62,025 $ 4 $ 137,497 $ 5,538 $ (1,450) $ (79,564)  
Beginning Balance, Shares at Dec. 31, 2020   39,510,108 107,592,801   483,479    
Exercise of common stock options 1,967     1,967      
Exercise of common stock options, Shares   2,020,709          
Stock-based compensation expense 11,881     11,881      
Exercise of Series D warrants 550   $ 550        
Exercise of Series D warrants, Shares     110,212        
Stock vested under compensation plan, shares   106,800          
Conversion of convertible preferred stock into common stock upon reverse recapitalization, converted $ 11 $ 138,047 138,036      
'Conversion of convertible preferred stock into common stock upon reverse recapitalization, converted, Shares   107,703,013 (107,703,013)        
Retirement of treasury stock upon reverse recapitalization     (1,450) $ 1,450    
Retirement of treasury stock upon reverse recapitalization, Shares   (483,479)     (483,479)    
Repurchase of common stock upon reverse recapitalization (45,000)     (45,000)      
Repurchase of common stock upon reverse recapitalization, Shares   (4,499,998)          
Issuance of common stock upon the reverse recapitalization, net of transaction costs 113,178 $ 2   113,176      
Issuance of common stock upon the reverse recapitalization, net of transaction costs, Shares   20,456,333          
Issuance of common stock related to PIPE Investment 210,000 $ 2   209,998      
Issuance of common stock related to PIPE Investment, Shares   21,000,000          
Recognition of derivative liability related to earnout (123,129)     (123,129)      
Earnout stock-based compensation expense 7,049     7,049      
Common stock issued for acquisitions 0            
Exercise of common stock warrants 1,793     1,793      
Exercise of common stock warrants (In Share)   179,572          
Net profit (loss) and comprehensive income (loss) 3,855         3,855  
Ending Balance at Dec. 31, 2021 244,169 $ 19   319,859   (75,709)  
Ending Balance, Shares at Dec. 31, 2021   185,993,058          
Exercise of common stock options 2,216     2,216      
Exercise of common stock options, Shares   1,997,314          
Stock-based compensation expense 16,607     16,607      
Stock vested under compensation plan, shares   1,555,988          
Stock vested under compensation plan (664)     (664)      
Earnout stock-based compensation expense 1,602     1,602      
Issuance of Common Stock in connection with acquisitions (InShare)   4,702,097          
Common stock issued for acquisitions 12,194     12,194      
Issuance of Common Stock in connection with acquisition (In Share)   312,489          
Issuance of Common Stock in connection with acquisition earnout achievement 750     750      
Other comprehensive income 1,068           $ 1,068
Net profit (loss) and comprehensive income (loss) (25,388)         (25,388)  
Ending Balance at Dec. 31, 2022 $ 252,554 $ 19   $ 352,564   $ (101,097) $ 1,068
Ending Balance, Shares at Dec. 31, 2022   194,560,946